Each filer's latest filing for 004890109 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
RA Capital Management, L.P.
13D/A
|
28.8% |
4/23/2026
Event 4/22/2026
|
||
| RA Capital Management, L.P. | 28.8% | |||
| Peter Kolchinsky | 28.8% | |||
| Rajeev Shah | 28.8% | |||
| RA Capital Healthcare Fund, L.P. | 27.7% | |||
|
Sands Capital Life Sciences Pulse Fund II, L.P.
13G/A
|
5.3% |
8/13/2026
Event 6/30/2026
|
||
| Sands Capital Life Sciences Pulse Fund II, L.P. | 5.3% | |||
| Sands Capital Alternatives, LLC | 5.3% | |||
| Sands Frank M. | 5.3% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
|
Citadel Advisors LLC
13G/A
|
0% |
5/15/2026
Event 3/31/2026
|
||
| Citadel Advisors LLC | 0% | |||
| Citadel Advisors Holdings LP | 0% | |||
| Citadel GP LLC | 0% | |||
| Citadel Securities LLC | 0% | |||
| Citadel Securities Group LP | 0% | |||
| Citadel Securities GP LLC | 0% | |||
| Kenneth Griffin | 0% | |||
|
Perceptive Advisors LLC
13G/A
|
0% |
6/4/2025
Event 6/2/2025
|
||
| Perceptive Advisors LLC | 0% | |||
| Joseph Edelman | 0% | |||
| Perceptive Life Sciences Master Fund, Ltd. | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 47 | 21.2 M | $43.4M |
| 2026 Q2 | 46 | 21.4 M | $38.1M |
| 2026 Q1 | 44 | 16.2 M | $22.6M |
| 2025 Q4 | 49 | 18.6 M | $44.9M |
| 2025 Q3 | 48 | 17.5 M | $32.7M |
| 2025 Q2 | 54 | 17.8 M | $21.2M |
| 2025 Q1 | 64 | 22.5 M | $45.7M |
| 2024 Q4 | 64 | 23.3 M | $140M |
| 2024 Q3 | 56 | 23.0 M | $161M |
| 2024 Q2 | 56 | 23.5 M | $136M |
| 2024 Q1 | 49 | 15.2 M | $109M |
| 2023 Q4 | 43 | 15.3 M | $74.5M |
| 2023 Q3 | 44 | 15.1 M | $144M |
| 2023 Q2 | 41 | 15.1 M | $196M |
| 2023 Q1 | 40 | 15.2 M | $191M |
| 2022 Q4 | 19 | 15.0 M | $170M |